FibroBiologics, Inc. Common Stock
USD0.79
-0.04 (-4.98%)
CEO
Peter O'Heeron
IPO Date
2024-02-01
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.80
Prev. Close
$0.83
Day Low
$0.78
Day High
$0.81
52W Low
$0.73
52W High
$14.68
Market Cap
$0.00B
Volume
0.16M
| 30,803 |
| $0.75 |
| 23 Jun 2026 | Link Matthew | director | A-Award | Acquired | 30,803 | $0.75 |
| 23 Jun 2026 | Niklas Victoria Ninon Olivia | director | A-Award | Acquired | 30,803 | $0.75 |
| 4 May 2026 | O'HEERON PETE | director, officer: CHIEF EXECUTIVE OFFICER | A-Award | Acquired | 92,410 | $1.38 |
| 4 May 2026 | Khoja Hamid | Chief Scientific Officer | A-Award | Acquired | 61,607 | $1.38 |
| 4 May 2026 | Davis Jason | Chief Financial Officer | A-Award | Acquired | 61,607 | $1.38 |
| 4 May 2026 | GARCIA RUBEN A | General Counsel | A-Award | Acquired | 61,607 | $1.38 |
| 5 Mar 2026 | Khoja Hamid | Chief Scientific Officer | P-Purchase | Acquired | 30,000 | $0.38 |
| 4 Mar 2026 | O'HEERON PETE | director, officer: CHIEF EXECUTIVE OFFICER | P-Purchase | Acquired | 18,200 | $0.41 |